Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002539376 | SCV001031986 | likely benign | Neuronal ceroid lipofuscinosis 13 | 2024-08-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000888356 | SCV001783087 | likely benign | not provided | 2019-03-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002346052 | SCV002651129 | likely benign | Inborn genetic diseases | 2017-06-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003955945 | SCV004775814 | likely benign | CTSF-related disorder | 2023-02-27 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |